Skip to main content

Mereo BioPharma Group plc

MREO
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
SEC CIK
0001719714

No open-market purchases or sales by Mereo BioPharma Group plc insiders were filed in the last 90 days; 60 institutions reported holding it in 13F filings for Q2 2026, worth $18.0M in total; no superinvestor holds it.

Q3 2021 vs. Q2 2021

How the institutions holding Mereo BioPharma Group plc changed between Q2 2021 and Q3 2021.

All holders in Q3 2021All holders in Q2 2021

13F holders of MREO: Q2 2021 compared with Q3 2021
MeasureQ2 2021Q3 2021Change
Holders7263−9
Shares73.3M88.4M+15.1M (+20.6%)
Value$284.4M$212.2M−$72.2M (−25.4%)

New holders (8)

Institutions that held Mereo BioPharma Group plc at the end of Q3 2021 but not at the end of Q2 2021.

Institutions new to MREO in Q3 2021
InstitutionSharesValue% of portfolio
Adage Capital Partners GP, L.L.C.1,000,000$2.42M0.00%
Eversept Partners, LP899,569$2.18M0.17%
Oppenheimer & Co Inc19,000$46.0K0.00%
Virtu Financial LLC12,202$30.0K0.00%
SRS Capital Advisors, Inc.4,000$10.0K0.00%
JPMorgan Chase & Co3,000$7.00K0.00%
Total Clarity Wealth Management, Inc.2,375$6.00K0.00%
Tower Research Capital LLC (TRC)629$2.00K0.00%

Sold out (17)

Institutions that held Mereo BioPharma Group plc at the end of Q2 2021 and filed for Q3 2021 without it.

Institutions that sold out of MREO in Q3 2021
InstitutionShares, Q2 2021Value, Q2 2021
Boxer Capital, LLC6,226,673$19.7M
Perceptive Advisors LLC1,696,068$5.38M
Asymmetry Capital Management, L.P.1,618,328$5.13M
Tri Locum Partners LP1,253,729$3.97M
Atom Investors LP269,390$854.0K
Pura Vida Investments, LLC196,570$623.0K
HealthCor Management, L.P.149,170$473.0K
Marshall Wace, LLP44,682$142.0K
Man Group plc27,400$87.0K
Windsor Creek Advisors, LLC15,000$48.0K
Wealthspire Advisors, LLC14,276$45.0K
Shay Capital LLC12,686$40.0K
Lindbrook Capital, LLC5,000$16.0K
Quadrant Capital Group LLC3,657$12.0K
Endurance Wealth Management, Inc.1,500$4.00K
Sit Investment Associates Inc970$3.00K
FMR LLC1$0